Abstract:Neuroblastoma (NB) is a the pediatric cancer of the early nerve cells in which solid tumors originate from the peripheral sympathetic nervous system and as such can occur primarily anywhere along the sympathetic chain with development on the adrenal gland being most common. The expression of the disease is highly variable as in some cases lead to spontaneously regression without any medical intervention whereas in other cases the tumors become highly metastatic and therapeutically resistant. Our results demonstrated that atypical protein kinase C-iota and zeta (aPKC-ι/ζ) levels were overexpressed in NB cells (BE-2C and BE-M17) and tissues. The present study shows the downstream effects PKC-ι specific inhibitor 5-amino-1-(2,3-dihydroxy-4-(hydroxymethyl)cyclopentyl)-1H-imidazole-4-carboxamide (ICA-1S) and a PKC-ζ specific inhibitor 8-hydroxy-1,3,6-naphthalenetrisulfonic acid (ζ-Stat) on aPKCs, 14-3-3, p-14-3-3, Akt1, NF-κB p65, Smad2/3 and p-Smad2/3. Decreased Vimentin and increased E-cadherin levels indicated the downregulation of epithelial-mesenchymal transition (EMT). Result also indicated that SNAIL1 transcriptional activity was downregulated as a result of aPKC diminution. SNAIL1 is known to induce EMT. 14-3-3 proteins have the ability to bind a multitude of functionally diverse signaling proteins, including kinases, phosphatases, and transmembrane receptors. Our immunoprecipitation (IP) data suggested that both aPKCs associate with 14-3-3 and Smad2/3. Our data also indicated that both 14-3-3 and Smad2/3 levels were significantly decreased as a result of aPKC inhibition. In addition, pIκB, NFκB p65, p-14-3-3, pAkt1, levels were significantly decreased. Our data indicates that 14-3-3 acts as a central key regulator in aPKC driven cell cycle progression in BE-2C and BE-M17 cells. In addition, we found that Smad2/3 plays a vital role in upregulation of aPKC driven Vimentin dynamics in NB cell lines in relation to 14-3-3. In-vitro migration/invasion assays, IP, immunofluorescence, real time qPCR and Western blot techniques were used to further analyze role of aPKCs in NB malignancy. Data confirmed that aPKC attenuation triggers multiple pro-apoptotic signaling cascades through downregulation of NFκB, Akt, and Smad pathways through downregulation of 14-3-3. In-vivo experiments on murine models are being conducted using ICA-1S and ζ-Stat. Excised tumors will be analyzed for pathways observed in in-vitro experiments. Overall results suggest that aPKCs are crucial for increased invasiveness in NB. Results suggested that aPKC can be targeted to develop customized, tailored therapies for NB which merit further research. Citation Format: Sloan Breedy. Oncogenic PKC-ι/PKC-ζ/14-3-3 and PKC-ι/PKC-ζ/Smad2/3 signaling cascades are crucial for increased invasiveness of Neuroblastoma cells [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl) nr 164.

Reconstructive surgery for overcorrected clubfoot in adults.

CAMKV Kinase Signaling Is a Novel Therapeutic Avenue with Prognostic Relevance in Neuroblastoma

Calcium-Regulatory Proteins As Modulators of Chemotherapy in Human Neuroblastoma

NCAPG is a Potential Biomarker for Prognosis of Treatment in Children with High-risk Neuroblastoma

Csig-22. Pharmacologic Inhibition And Knockdown Of Camk2 Impair Growth Of Patient-Derived Glioblastoma Cultures

Identification of NCAPG as an Essential Gene for Neuroblastoma Employing CRISPR-Cas9 Screening Database and Experimental Verification

Mat1-Modulated Cyclin-Dependent Kinase-Activating Kinase Activity Cross-Regulates Neuroblastoma Cell G(1) Arrest And Neurite Outgrowth

CaMKII-mediated Beclin 1 Phosphorylation Regulates Autophagy That Promotes Degradation of Id and Neuroblastoma Cell Differentiation

ADGRL4 Promotes Cell Growth, Aggressiveness, EMT, and Angiogenesis in Neuroblastoma via Activation of ERK/STAT3 Pathway

[Role and mechanism of cysteine and glycine-rich protein 2 in the malignant progression of neuroblastoma]

Smoothened-Independent Activation of Hedgehog Signaling by Rearranged During Transfection Promotes Neuroblastoma Cell Proliferation and Tumor Growth

Targeting CAMK2N1/CAMK2 inhibits invasion, migration and angiogenesis of non-small cell lung cancer by promoting autophagy and apoptosis via AKT/mTOR signaling pathway

10-Hydroxycamptothecin induces apoptosis in human neuroblastoma SMS-KCNR cells through p53, cytochrome c and caspase 3 pathways.

Epac activation reduces trans-endothelial migration of undifferentiated neuroblastoma cells and cellular differentiation with a CDK inhibitor further enhances Epac effect.

Abstract 164: Oncogenic PKC-ι/PKC-ζ/14-3-3 and PKC-ι/PKC-ζ/Smad2/3 signaling cascades are crucial for increased invasiveness of Neuroblastoma cells

A novel cuproptosis-related subtypes and gene signature associates with immunophenotype and predicts prognosis accurately in neuroblastoma

METTL3/MYCN cooperation drives neural crest differentiation and provides therapeutic vulnerability in neuroblastoma

Comprehensive analysis and validation reveal potential MYCN regulatory biomarkers associated with neuroblastoma prognosis

Rho GTPases signaling mediates aggressiveness and differentiation in neuroblastoma tumors

BRD4 Inhibitor MZ1 Exerts Anti-Cancer Effects by Targeting MYCN and MAPK Signaling in Neuroblastoma.

A Novel Druggable Dual-Specificity tYrosine-Regulated Kinase3/Calmodulin Kinase-like Vesicle-Associated Signaling Module with Therapeutic Implications in Neuroblastoma